Business Context and Reporting Period
Company: Medirom Healthcare Technologies Inc.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: December 2025 (Filed December 15, 2025)
Principal Office: Tokyo, Japan
This filing reports the closing of a capital raise transaction involving the issuance of convertible corporate bonds.
Key Financial Metrics
Capital Raised: JPY 400,000,000 (Aggregate principal amount)
Net Proceeds: Approximately JPY 400,000,000
Instrument: Third Unsecured Convertible-Type Corporate Bonds with Share Options
Investors: 11 Bond Holders
Use of Proceeds: General corporate or financing purposes
Note: The filing does not provide specific data on revenue, profit, cash flow, operating margins, existing debt levels, or liquidity ratios. It focuses solely on the bond issuance transaction.
Material Changes
- Debt Structure: The Company has increased its debt obligations by issuing JPY 400,000,000 in unsecured convertible bonds.
- Equity Dilution Potential: The issuance includes share options, creating potential future dilution for existing shareholders upon conversion.
- Liquidity Event: The transaction closed on December 12, 2025, providing immediate cash inflow.
Guidance, Outlook, and Risks
Management Commentary: The Company intends to utilize the proceeds for general corporate purposes as deemed appropriate. No specific operational guidance or financial outlook was provided in this filing.
Risks and Contingencies:
- Forward-Looking Statements: The filing includes standard disclaimers that actual results may differ materially from expectations due to significant risks and uncertainties.
- Regulatory Status: The bonds were issued outside the United States under Regulation S. They are not registered under the U.S. Securities Act and cannot be offered or sold in the U.S. absent registration or an applicable exemption.
- Transaction Risk: While the transaction is closed, the filing notes general risks that transactions may not be consummated or may have adverse impacts if consummated (standard legal language).
Investor Verification Checklist
- Verify the specific conversion terms and exercise price of the share options attached to the bonds (refer to Exhibit 4.1 Indenture).
- Confirm the impact of this JPY 400,000,000 issuance on the Company's total debt-to-equity ratio.
- Review the "Risk Factors" section of the Company's most recent Form 20-F (filed April 29, 2025) for detailed operational risks.
- Monitor future filings for the specific allocation of the "general corporate" proceeds.